In a string of tweets, Citron referred to Express Scripts as the “Philidor of the pharma industry.” Philidor is a specialty pharmacy accused of using aggressive tactics and trickery to drive up reimbursements from insurers for costly medications.
The remarks from Citron come after President-elect Trump revealed his intentions to “bring down drug prices” during an interview with Time.
Andrew Left is the activist short seller, author and editor behind online investment newsletter Citron Research.
In response to the tweets, an Express Scripts spokesperson told Investor’s Business Daily, “We’re nothing like Philidor. As you may recall, we removed Philidor from our network more than a year ago.”
The spokesperson added Express Scripts was “a market force that uniquely puts medicine within reach by driving down cost of care and improving health outcomes.”
More articles on supply chain issues:
Opinion: Why supply chain execs must take the lead in stopping climate change
Survey: 48% of U.S. manufacturers list unqualified workers as largest barrier to growth
athenahealth CEO Jonathan Bush on what everyone gets wrong about high drug prices
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
